Exosome membrane-biomimetic nanomedicine targets the pre-metastatic niche &lt;i&gt;via&lt;/i&gt; NF-κB inhibition to suppress breast cancer lung metastasis. The gene discussed is NFKB1; the disease is breast carcinoma.